The Pharma & Biotech Patent Litigation Summit, North America 2025, is a premier event organized by RWS, a global leader in intellectual property services. This summit is dedicated to bringing together over 250 industry experts in Philadelphia to address the most pressing challenges in contentious IP law within the life sciences sector.
Key topics at the summit include strategies for structuring and mitigating risks in cross-border litigation cases, enhancing patent protection post Re: Cellect, and preparing for Europe's significant patent market shift with the Unified Patent Court (UPC). Attendees will gain insights into the latest case law, regulatory updates, and strategic litigation approaches.
The event offers extensive networking opportunities, including an expo hall where participants can engage with leading solution providers. Notable speakers from RWS, such as Craig Havertape and Morris Wilder, will share their expertise on critical issues like the role of prior art in ensuring successful litigation outcomes.
This summit is essential for Chief IP Counsels, General Counsels, and other legal professionals in the pharmaceutical and biotechnology industries seeking to stay ahead in the evolving landscape of patent litigation. Attendees will benefit from in-depth discussions, practical workshops, and the chance to connect with peers and industry leaders.
Speakers(2)
Craig Havertape
Account Manager, Patent Research at RWS IP Solutions
Craig Havertape is an Account Manager specializing in patent research at RWS IP Solutions.
Morris Wilder
Senior Director, IP Solutions at RWS IP Solutions
Morris Wilder serves as the Senior Director of IP Solutions at RWS IP Solutions.
Event Details
- Date
- November 18-19, 2025
- 2 days
- Location
- 🇺🇸 Philadelphia, United States
- 1201 Market Street, 1200 Filbert St, Philadelphia, PA 19107
- Audience
- Chief IP Counsels, General Counsels, legal professionals in the pharmaceutical and biotechnology industries
- Attendees
- Over 250 industry experts